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upregulation of mast cells in wall of ruptured
human cerebral aneurysms: preliminary results
David Hasan1,4*, Nohra Chalouhi2, Pascal Jabbour2 and Tomoki Hashimoto3

Abstract
Background: M1 and M2 cells are two major subsets of human macrophages that exert opposite effects on the
inflammatory response. This study aims to investigate the role of macrophage M1/M2 imbalance and mast cells in
the progression of human cerebral aneurysms to rupture.
Methods: Ten patients with cerebral aneurysms (five ruptured and five unruptured) underwent microsurgical
clipping. During the procedure, a segment of the aneurysm dome was resected and immunostained with
monoclonal antibodies for M1 cells (anti-HLA DR), M2 cells (anti-CD 163), and mast cells (anti-tryptase clone AA). A
segment of the superficial temporal artery (STA) was also removed and immunostained with monoclonal antibodies
for M1, M2, and mast cells.
Results: All ten aneurysm tissues stained positive for M1, M2, and mast cells. M1 and M2 cells were present in
equal proportions in unruptured aneurysms. This contrasted with a marked predominance of M1 over M2 cells in
ruptured aneurysms (p = 0.045). Mast cells were also prominently upregulated in ruptured aneurysms (p = 0.001).
Few M1 and M2 cells were present in STA samples.
Conclusions: M1/M2 macrophages and mast cells are found in human cerebral aneurysms; however, M1 and mast
cell expression seems to markedly increase in ruptured aneurysms. These findings suggest that macrophage M1/M2
imbalance and upregulation of mast cells may have a role in the progression of cerebral aneurysms to rupture.
Keywords: Aneurysm, Inflammation, Macrophages, M1, M2, Mast cells

Background
Monocytes originate from bone marrow-derived progenitor cells and do not proliferate in the blood [1-4].
Mononuclear phagocytes develop into morphologically
and functionally distinct cell types in response to the tissue microenvironment (e.g., lung alveolar macrophages,
Kupffer cells, decidual macrophages) [5,6]. Two major
subsets of human macrophages can be defined in atherosclerotic plaques: CD14highCD16low macrophages,
which typically represent 85% to 95% of monocytes, and
CD14lowCD16high macrophages, which account for the
remaining 5 to 15% [2-4,7]. These macrophages play
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opposite roles in inflammation [2-4,7]. A growing body
of evidence suggests that a polarized macrophage population can contribute to systemic and neuroinflammatory
diseases [8,9].
Macrophages play a critical role in cerebral aneurysm
formation and rupture [10-13]. Macrophage depletion
and knockout of monocyte chemotactic protein-1 gene
in mice reduce the incidence cerebral aneurysm formation [13]. Recent studies also have revealed that mast
cells contribute to various vascular diseases through degranulation and release of cytokines including cerebral
aneurysm formation [14,15].
We hypothesize that macrophage imbalance and upregulation of mast cells are more pronounced in ruptured
compared to unruptured human cerebral aneurysms.
The goal of this study is to provide immunohistological
evidence of this hypothesis.

© 2012 Hasan et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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Material and methods
The study was approved by the University of Iowa Institutional Review Board (IRB). Ten consecutive patients
with cerebral aneurysms who underwent microsurgical
clipping during a 6-month interval were identified. No
patients were excluded, except those who were treated
with endovascular means. Five patients with unruptured
aneurysms and five patients with ruptured aneurysms
were included in the study. Mean age was 55 years
(range 44–67 years) (Table 1). Informed consent was
obtained in all patients prior to microsurgical clipping.
A segment of the aneurysm dome (≥1 mm) and the
superficial temporal artery (STA) (≥2 mm) was removed
from each patient and placed in formalin. All 20 specimens (10 aneurysms and 10 STAs) were immunostained with monoclonal antibodies to mast cells using
anti-mast cells tryptase clone AA1 (DakoCytomation,
Carpentaria, CA), M1 cells using anti-HLA DR (ABCAM,
Cambridge MA), and M2 cells using anti-CD 163
(ABCAM, Cambridge MA).
The entire tissue sample collected from the aneurysm
dome was embedded in paraffin and analyzed. The sample size, however, differed from one patient to another
based on the size of the aneurysm and ease of tissue collection following successful clipping. All fields were analyzed per sample and, for consistency, we chose the field
with the highest concentration of cells for semiquantitative analysis. Each field covered the entire section of the

aneurysm tissue and included all layers of the wall of the
aneurysm dome.
Semiquantitative analysis of the slides was performed
based on cell count (immunostained positive cells) per
high-power field (HPF) (40×): grade 0 = 0–10 cells per
HPF, grade 1 = 10–20 cells per HPF, grade 2 = 20–30
cells per HPF, and grade 3 ≥ 30 cells per HPF. All specimens were assessed by an observer who was blinded to
the clinical data and source of tissue.
Statistical analysis was performed using the KruskalWallis test, a nonparametric ANOVA test. This test is
used for comparing more than two samples that are independent, or not related. The parametric equivalence of the
Kruskal-Wallis test is the one-way analysis of variance
(ANOVA). The factual null hypothesis is that the populations from which the samples originate have the same median. When the Kruskal-Wallis test leads to significant
results, then at least one of the samples is different from
the other samples. The test does not identify where the
differences occur or how many differences actually occur.

Results
Ten patients with ten aneurysms were included in this
study. All ten aneurysms stained positive for expression
of M1, M2, and mast cells using anti-HLA DR, anti-CD
163, and anti-mast cells tryptase clone AA1 monoclonal
antibodies (Figures 1 and 2).

Table 1 Patient and aneurysm characteristics
Patient no.

Age

Sex

Aneurysm location

Aneurysm size (mm)

Rupture
(SAH)

M1
A/STA

M2
A/STA

Mast
cells

1

50

F

L-ICA

9×6

No

1/0
(13/4)

1/0
(11/5)

1
(4)

2

56

M

R-MCA

5×4

No

1/0
(15/7)

1/0
(11/4)

1
(7)

3

52

F

L-MCA

10 × 10

No

2/0
(27/3)

1/0
(18/6)

1
(5)

4

67

F

R-MCA

7×8

No

2/0
(26/5)

2/0
(27/4)

1
(3)

5

47

M

R-Pcomm

14 × 11

No

2/0
(28/7)

2/0
(27/5)

1
(5)

6

68

M

L-MCA

12 × 9

Yes

3/0
(39/6)

1/0
(12/3)

3
(41)

7

44

M

R-MCA

6×5

Yes

3/1
(41/2)

2/1
(22/4)

3
(39)

8

38

F

A-comm

8×8

Yes

3/0
(37/3)

1/0
(14/7)

3
(31)

9

55

F

L-MCA

9 × 10

Yes

3/0
(44/6)

1/0
(13/4)

3
(49)

10

74

M

R-PICA

14 × 15

Yes

3/0
(38/4)

1/0
(15/6)

3
(34)

F = female; M = male; L = left; R = right; ICA = internal carotid artery; MCA = middle cerebral artery; A-Comm = anterior communicating artery; Pcomm = posterior
communicating artery; PICA = posterior communicating artery; A/STA = aneurysm/superficial temporal artery; grade 0 = 0–10 cells per HPF, grade 1 = 10–20 cells
per HPF, grade 2 = 20–30 cells per HPF, and grade 3 ≥ 30 cells per HPF. Numbers in parentheses are absolute cell counts.
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Figure 1 Immunostaining of monoclonal antibodies with anti-HLA DR for M1 and anti-CD 163 for M2 cells. In ruptured aneurysms, there
is a clear predominance of M1 over M2 cells (1A-1B). In unruptured aneurysms, M1 cell count is almost the same as M2 (2A-2B). The expression
of M1 and M2 cells is almost similar in STA specimen, but significantly lower than in ruptured and unruptured aneurysms (3A-3B).

Figure 2 Immunostaining of monoclonal antibodies for anti-mast cells tryptase (clone AA1). There are more mast cells visible in ruptured
aneurysms than in unruptured aneurysms.
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Macrophages

Unruptured aneurysms stained almost equally for M1
and M2 cells. Ruptured cerebral aneurysms, however,
stained more abundantly with anti-HLA DR monoclonal
antibodies, indicating a predominance of M1 over M2
cells. There was only scant staining of M1 and M2 cells
in the ten samples of STA tissue (Figure 1).
Mast cells

Unruptured aneurysms had few mast cells. Ruptured
aneurysms had prominently more mast cells stained with
monoclonal antibody for anti-mast cells tryptase clone
AA1 compared with unruptured aneurysms. There was
abundant mast cell staining in STA tissue but this was
limited to adventitia and did not extend to the other
layers, namely the media, intima, and subendothelium
(Figure 2).
Statistical analysis

Areas immunostained for M1 and M2 cells with
cell count differences were localized, and semiquantitative analysis was performed (Figure 3). M1 cell expression was significantly higher than M2 cell expression
(p = 0.045) in ruptured aneurysms. M1 cell expression
was also greater (p = 0.001) in ruptured and unruptured
aneurysms vs. STA. Mast cell expression was significantly higher in ruptured aneurysms vs. unruptured
aneurysms (p = 0.001).

Discussion
Monocyte differentiation into M1 and M2 subsets

Monocytes differentiate into heterogeneous cells [1-4,16].
Differential expression of selected surface molecules is
used to identify monocyte subsets in humans and mice. In
humans, there are two distinct subsets of macrophages
based on the expression of CD16 [7]. CD14high/CD16low
cells are the primary subtype of macrophages as they represent 80% to 90% of circulating monocytes and express
high levels of the chemokine receptor CCR2 and low
levels of CX3CR1. They are poor producers of inflammatory cytokines but release interleukin (IL) 1, IL 13, IL 14,
IL 4, IL-10, transforming growth factor-β (TGF-β), and
vitamin D. Conversely, CD14low/ CD16high monocytes
have a CX3CR1high/CCR2low phenotype and account for
inflammatory mediator production, including tumor necrosis factor-α (TNF-α), IL 1, IL 6, IL 12, IL 23, matrix
metalloproteinases (MMP), prostaglandins, and leukotrienes [1-4,7]. In mice, monocytes differentiate into two
major types of macrophages (M1 and M2) [1-4,6,17,18].
M1 and M2 macrophages play opposite roles during inflammation, although both are present in atherosclerotic
lesions. M1 macrophages are differentiated from Ly6Chigh
monocytes. They promote inflammation by producing
high levels of IL-2, IL-23, IL-6, IL-1, and TNF-α. M2

Figure 3 Semiquantitative grading for M1, M2, and mast cells
in ruptured and unruptured aneurysms. The number of M1 and
M2 cells in unruptured aneurysms is almost equal, with significantly
more M1 cells noted in ruptured aneurysms. Clearly more mast cells
are present in ruptured aneurysms compared to unruptured
aneurysms.

macrophages, on the other hand, are differentiated from
Ly6Clow monocytes. They differentiate in the presence of
IL-4, IL-13, IL-1, or vitamin D3, tend to produce a large
amount of IL-10, and express scavenger receptors, mannose receptors, and arginase [1-5]. Unlike M1 macrophages, these cells promote resolution of inflammation.
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Figure 4 M1 vs. M2 balance. Schematic diagram illustrating our
hypothesis that a balance between M1 and M2 cells leads to stable
aneurysm and that imbalance between M1 and M2 cells with
increased population of M1 cells and upregulation of mast cells
predisposes the aneurysm to rupture.

Recently, there has been a great deal of interest in
macrophage heterogeneity in atherosclerotic lesions,
particularly regarding the roles of M1 versus M2 macrophages. There is also evidence that an imbalance in the
ratio of M1 to M2 macrophages in advanced atherosclerosis impairs resolution of inflammation in vitro [1-5].
Macrophages and cerebral aneurysms

Macrophage-depleted and monocyte chemotactic protein-1
knockout mice have a reduced incidence of cerebral
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aneurysms [13]. Macrophages were observed in the wall
of hypertension-induced cerebral aneurysms in rats and
were reported to secrete extracellular matrix-degrading
proteolytic enzymes and induce apoptosis of smooth
muscle cells [12]. Additionally, macrophages induce fibrosis through secretion of TGF-β and promote the release of
reactive oxygen species, TNF-α and IL-1 [10]. Macrophages are also an important source of MMP 2 and 9,
which presumably contribute to the reduction of mechanical strength and rupture of aneurysms. MMP-2 is
expressed in most cerebral aneurysms, whereas MMP-9
is expressed primarily in aneurysms with atherosclerotic changes [19,20]. Macrophages are an especially
important source of growth factors and cytokines that
stimulate fibrosis [3].
Platelet-derived growth factor, basic fibroblast growth
factor (bFGF), and transforming growth factors alpha
(TGF-α) and beta are expressed by immunohistochemistry in intracranial aneurysms [20-23]. Transcription of
procollagens I and III is promoted by TGF-β, secreted in
large part by macrophages [24]. In aneurysms, the progression of smooth muscle cells from a contractile to a
synthetic phenotype and the increase in relative numbers
of smooth muscle cells (by increased proliferation of
smooth muscle cells and myointimal hyperplasia) may
compensate for the increased MMP expression and sustain aneurysm wall strength [25]. In concordance with this
theory, the aneurysm wall shows, by in situ hybridization,

Figure 5 Polarized monocytes and cytokine production. Schematic diagram demonstrating two populations of monocytes (CD14high
CD16low, CD14low CD16high) and their polarization to two subtypes of macrophages (M1 and M2) with their cell-specific cytokine production.
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increased synthesis of collagen type III but a slight diminution in expression of collagen type III in immunostaining, probably indicating faster collagen turnover.
Mural cells die during aneurysm progression and the
extracellular matrix-synthesizing capability is progressively lost, leading to a decrease in tensile wall strength
and an increase in susceptibility of the aneurysm to
rupture [25].
Based on the classification of atherosclerosis by histological changes, nearly all cerebral aneurysms can be
considered atherosclerotic [26]. Features of advanced
atherosclerosis (including a core of atheromatous debris,
a fibrous cap with macrophages and T-cells) are observed
in approximately half of intracranial aneurysms [11,26],
and myointimal hyperplasia occurs in the other half [25].
Thrombosis occurs in some cerebral aneurysms, which
further amplifies the ongoing inflammatory reaction and
wall degeneration, with loss of tensile strength and ultimately aneurysm rupture [24,27-32].
Mast cells and cerebral aneurysms

Ishibashi et al. [14] examined the role of mast cells in
the formation of cerebral aneurysms in an experimental
rat model. They found that the number of mast cells
was significantly increased in aneurysm walls. They also
showed that using mast cell degranulation inhibitors
attenuated the chronic inflammatory process in the
aneurysm wall. This was evident from the decreased nuclear factor-kappa B activation, macrophage infiltration,
and expression of monocyte chemoattractant protein-1,
MMP, and interleukin-1beta. They also demonstrated
that the degranulation of mast cells led to increased expression and activation of MMP-2 and -9 and induced
nitric oxide synthase in cultured smooth muscle cells
from rat intracranial arteries. Their results suggest that
mast cells play a critical role in aneurysm formation in
rats through the induction of inflammation. However,
they did not address the question of whether mast cells
contribute to the progression of cerebral aneurysms to
rupture and whether these cells are present in human
cerebral aneurysm tissue.
Interpretation of current findings

We found that M1 and M2 cells were present in equal
proportions in unruptured aneurysms with very few
mast cells, which suggests that the pro- and antiinflammatory activities of M1 and M2 cells, respectively, may
be well balanced in the walls of unruptured aneurysms
(Figure 4). However, ruptured aneurysms appear to lose
this critical M1/M2 balance, as M1 cell expression was
significantly more pronounced than M2 cell expression
in ruptured aneurysm walls. Additionally, mast cells
were found to be significantly upregulated in ruptured
cerebral aneurysm tissue. Collectively, these data suggest
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Figure 6 Mast cell – macrophage interaction. Schematic diagram
demonstrating the interaction of mast cells with macrophages (M1
cells) and their cytokine production implicated in aneurysm
formation and rupture.

that a polarized proinflammatory response involving M1
macrophages and mast cells may have a role in the cascade of events leading to aneurysm rupture (Figures 5
and 6). However, the relationship between macrophage
subsets and mast cells remains to be defined.
Limitations

This study is limited by the small sample size, and
generalization of the results may not be appropriate. It
also is difficult to determine whether increased expression of M1 vs. M2 and upregulation of mast cells in ruptured cerebral aneurysms (compared to non-ruptured) is
due to inflammation that occurs following the rupture of
the aneurysm or whether there was an increase in expression of these molecules that preceded and led to
rupture of the aneurysm.

Conclusion
M1, M2, and mast cells are expressed in the walls of
human cerebral aneurysms. However, M1 and mast cell
expression may increase significantly in ruptured aneurysms. Our findings suggest that macrophage M1/M2 imbalance and upregulation of mast cells may play a role
in the progression of cerebral aneurysms to rupture.
Mast cell activation and M1/M2 macrophage phenotypic
modulation may represent important targets for future
therapy.
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